Change is in the air for the California stem cell agency, CIRM. It has a new President, Randy Mills, and CIRM is soon going to be like a new agency too. I recently did an interview with Mills that illuminates some of the big changes that are imminent. I also asked him what his favorite […]
Radical Vision for CIRM Future: Interview with New Prez Mills Read More »
The FDA has issued a warning letter to Cell Vitals, a company that manufactures and sells stem cell face creams. Cell Vitals is apparently owned by Irene Hardy according to the letter and the business has an address in Irvine, CA. A screenshot from their website is shown below. The stem cell creams sold by Cell Vitals
FDA warning letter to stem cell face creams maker Read More »
What are super cells? Guest post by Lisa Willemse Last month, on this blog, Paul wrote an article about loopholes in the clinicaltrials.gov database that allows for-profit companies to advertise their “therapies” under the guise of a registered clinical trial. This is a real concern for our community, especially those among us who have recommended
Super Cells exhibit and why we bother with public outreach Read More »
The STAP cell mess that began in January of this year has in some ways quieted down. In a broader sense, I believe that STAP is now and will be in the future viewed as a scandal that revealed some less than ideal aspects to the world of biomedical science and publishing. Where does this
STAP Cell Update: STAP-like paper, Real Origin of STAP cells Read More »
Here is a link to the Ocata website, marking the start of a new era for what was formerly Advanced Cell Technology or ACT. It’s been a big summer for stem cell biotech Advanced Cell Technology (ACT; stock ACTCD) as it continues what I would call a process of reinventing itself. What’s been happening? ACT recently
ACT reinventing itself with new name Ocata Therapeutics Read More »
Yesterday was a crazy day for the STAP cell situation. We had RIKEN releasing a scathing internal investigatory report and then some folks in the media got all worked up about a single PCR assay result that Dr. Ken Lee posted on ResearchGate. Some of the reporters/science writers hyped their headlines/articles on this situation as though
Dr. Lee STAP Result, Hyped by Media, in Proper Context Read More »
I’m a seismologist at the University of Tokyo, where I’ve been since 1984. I was the first tenured foreign faculty member in the history of our university. If you look at my publication list on the Researcher ID site you can see that my main research recent interests are modeling seismic wave propagation and analyzing
Seismologist from Japan looks at the STAP cells mess Read More »
Stem cell biotech, Advanced Cell Technology (ACT; stock symbol ACTC), has started off 2014 with indications that it is in a phase of rapid evolution. Some changes, such as today’s announced departure of now former CEO Gary Rabin (see my 2013 interview with him here), are already in the public domain, but other big developments
Big Changes Unfolding at Advanced Cell Technology (ACTC) Read More »
Stem Cells for Alzheimer’s Disease? Below is an excerpt focused on Alzheimer’s Disease from my new book on stem cells. Stem Cells: An Insider’s Guide, which is targeted to a broad audience of people interested in stem cells. Alzheimer’s Disease (AD) is one of the most devastating illnesses. It destroys the brain, which shrinks over
Book Excerpt: Stem Cells for Alzheimer’s Disease–Are We There yet? Read More »
Osiris, a cellular therapy biotech, recently received a so-called “untitled letter” from the FDA. The text of the letter seems on the whole negative in my opinion, while the company’s public reaction to the letter on the other hand could be seen paradoxically as rather cheery. What’s going on here? With Halloween coming, one has
Osiris FDA Letter: Trick or Treat? Read More »